Albumin administration in the acutely ill: What is new and where next?

Jean Louis Vincent, James A. Russell, Matthias Jacob, Greg Martin, Bertrand Guidet, Jan Wernerman, Ricard F. Roca, Stuart A. McCluskey, Luciano Gattinoni

Research output: Contribution to journalArticle

Abstract

Albumin solutions have been used worldwide for the treatment of critically ill patients since they became commercially available in the 1940s. However, their use has become the subject of criticism and debate in more recent years. Importantly, all fluid solutions have potential benefits and drawbacks. Large multicenter randomized studies have provided valuable data regarding the safety of albumin solutions, and have begun to clarify which groups of patients are most likely to benefit from their use. However, many questions remain related to where exactly albumin fits within our fluid choices. Here, we briefly summarize some of the physiology and history of albumin use in intensive care before offering some evidence-based guidance for albumin use in critically ill patients.

Original languageEnglish
Article number231
JournalCritical Care
Volume18
Issue number4
DOIs
Publication statusPublished - Jul 16 2014

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint Dive into the research topics of 'Albumin administration in the acutely ill: What is new and where next?'. Together they form a unique fingerprint.

  • Cite this

    Vincent, J. L., Russell, J. A., Jacob, M., Martin, G., Guidet, B., Wernerman, J., Roca, R. F., McCluskey, S. A., & Gattinoni, L. (2014). Albumin administration in the acutely ill: What is new and where next? Critical Care, 18(4), [231]. https://doi.org/10.1186/cc13991